Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117130) titled 'Association Analysis of Blood Microbiome (2bRAD-M) and Metabolomic Characteristics in Patients with Atherosclerotic Cardiovascular Disease' on Jan. 20.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Qingdao Traditional Chinese Medicine Hospital (Qingdao Hiser Hospital Affiliated to Qingdao University)
Condition:
atherosclerotic cardiovascular disease
Intervention:
ASCVD case group:None
Recruitment Status: Not Recruiting
Phase: Retrospective study
Date of First Enrollment: 2026-01-20
Target Sample Size: ASCVD case group:800;Healthy control group:200;
Countries of Recruit...